The artic cod liver (Gadus Morhua) is the only fish that delivers the LC MUFA (Long Chain Monounsaturated Fatty Acids) fatty acid which is unique to the artic cod liver and therefore guarantees north-Atlantic origin. LC MUFA is an omega 9 fatty acid.
The cod liver oil is based on North-Atlantic wild-caught cod fish (Gadus Morhua) based on the good fatty acids: EPA, DPA, DHA & LC MUFA. While Omega 3 fatty acids such as EPA, DHA & DPA are well-known, LC MUFA might be more unfamiliar to most people. North Atlantic fish protect against disease in icy waters with monounsaturated fat called LC-MUFA.
LC MUFA ensures that the North Atlantic wild cod stay agile in cold waters. Fish from other parts of the world do not have these monounsaturated fatty acids because they live in warmer sea temperatures. Unlike omega-3 and omega-6, omega-9 fatty acids are not considered essential, as they can be synthesized in the body from unsaturated fats. Omega-9 fatty acids are fatty acids that are stored in our body fat. Our fat cells make omega-9 fats from the fatty acids our body does not burn for energy. Omega-9 fatty acids are found in olive oil, almond oil, walnuts, animal fats, fish, and avocados. Replacing saturated fat in the diet with unsaturated fatty acids such as omega-9, omega-3 or omega-6 fatty acids, helps maintain a normal level of blood cholesterol. High cholesterol is a risk factor in the development of cardiovascular disease. In 2003, the US health authorities issued a clear health recommendation to the Americans to ingest
more cod liver oil. Every year, 500,000 people die of heart attacks in the United States alone, and the government believes their recommendations can help improve the health of Americans. The Norwegian National Council for Nutrition recommends that everyone have a daily intake of 5 ml cod
liver oil* (*except children less than 1 years old) Studies show that LC-MUFA can increase the uptake of omega-3 fatty acids in the body by up to 55 percent. This monounsaturated fat can also contribute to a significant reduction in chronic
inflammation of a low degree. In animal studies, unfavorable LDL cholesterol fell by 67 percent and triglycerides by 42 percent.
Early studies on mice and humans of LC MUFA have indicated promising results on lifestyle diseases such as metabolic syndrome, diabetes 2 and to a certain extent cardio protection (atherosclerosis).
However, more studies are needed to prove a direct cause effect relationship.